[Recurrent hemoptysis. 65-year-old post-kidney transplant patient with bilateral thoracic wall tumors].
II. Medizinische Klinik, SKU Klinikum Augsburg und KH Haunstetten, Stenglinstrasse 2, 86156 Augsburg.
R
R
Schulze
M
M
Schulze
A
A
Salomon-Dani
H
H
Weihprecht
K
K
Bohndorf
H
H
Arnholdt
G
G
Schlimok
D000368:Aged; D001706:Biopsy; D001859:Bone Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000556:secondary*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D006325:Heart Atria / Q000276:immunology / Q000473:pathology; D006338:Heart Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D006394:Hemangiosarcoma / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000556:secondary*; D006469:Hemoptysis / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D011183:Postoperative Complications / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D012272:Ribs / Q000276:immunology / Q000473:pathology; D013899:Thoracic Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000556:secondary*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone